BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Tenax Therapeutics
TENX
$60.6M
| $906K | ﹤0.01% |
320
| – | – |
|
4402
Coda Octopus Group
CODA
$115M
| $898K | ﹤0.01% |
100,245
+15,310
| +18% | +$136K |
|
4403
Flux Power
FLUX
$11.5M
| $894K | ﹤0.01% |
176,053
+103
| +0.1% | +$871 |
|
4404
Cumberland Pharmaceuticals
CPIX
$119M
| $892K | ﹤0.01% |
333,051
-62,973
| -16% | -$187K |
|
4405
FerroAtlántica
GSM
$854M
| $886K | ﹤0.01% |
101,954
+4,849
| +5% | +$33K |
|
4406
Natural Health Trends
NHTC
$14.9M
| $884K | ﹤0.01% |
123,287
+14,829
| +14% | +$103K |
|
4407
Inuvo
INUV
$17M
| $883K | ﹤0.01% |
126,263
+1,086
| +0.9% | +$8.47K |
|
|
AXLA
4408
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $883K | ﹤0.01% |
11,847
-44
| -0.4% | -$3.77K |
|
|
HMNF
4409
DELISTED
HMN Financial Inc
HMNF
| $882K | ﹤0.01% |
38,177
-375
| -1% | -$8.54K |
|
4410
Eastern Company
EML
$147M
| $871K | ﹤0.01% |
34,649
-1,048
| -3% | -$29.3K |
|
4411
NanoViricides
NNVC
$34.7M
| $868K | ﹤0.01% |
186,984
-560
| -0.3% | -$2.33K |
|
4412
Theriva Biologics
TOVX
$10.6M
| $863K | ﹤0.01% |
7,508
| – | – |
|
4413
LCNB Corp
LCNB
$282M
| $857K | ﹤0.01% |
49,008
-14,348
| -23% | -$245K |
|
4414
Aptevo Therapeutics
APVO
$6.28M
| – | – |
0
| – | – |
|
4415
Fuel Tech
FTEK
$43.7M
| $853K | ﹤0.01% |
490,083
-730
| -0.1% | -$1.38K |
|
4416
Minerva Neurosciences
NERV
$206M
| $850K | ﹤0.01% |
61,046
+10,238
| +20% | +$154K |
|
4417
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.02B
| $847K | ﹤0.01% |
8,219
| – | – |
|
4418
Inspired Entertainment
INSE
$164M
| $841K | ﹤0.01% |
71,852
-2,620
| -4% | -$30.6K |
|
|
ADIL
4419
Adial Pharmaceuticals
ADIL
$9.43M
| $837K | ﹤0.01% |
312
-1
| -0.3% | -$2.09K |
|
4420
Viridian Therapeutics
VRDN
$2.6B
| $836K | ﹤0.01% |
50,841
+589
| +1% | +$8.64K |
|
4421
CervoMed
CRVO
$41.8M
| $834K | ﹤0.01% |
21,818
| – | – |
|
4422
Oragenics
OGEN
$2.48M
| $830K | ﹤0.01% |
726
| – | – |
|
4423
ReNew
RNW
$2.5B
| $826K | ﹤0.01% |
+80,936
| New | +$809K |
|
|
CVLY
4424
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $824K | ﹤0.01% |
36,569
-3,768
| -9% | -$82.7K |
|
4425
Lantronix
LTRX
$264M
| $820K | ﹤0.01% |
140,773
-8,116
| -5% | -$44.6K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.